TickerFactsScreenerDevelopers

KYNTRA BIO, INC. (KYNB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $7.11M2017: -$66.51M2018: -$76.14M2019: -$78.70M2020: $81.60M2021: -$82.23M2022: -$145.93M2023: -$315.02M2024: -$138.00M2025: -$4.77M-$4.77M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$4.77M+96.5%
2024-$138.00M+56.2%
2023-$315.02M-115.9%
2022-$145.93M-77.5%
2021-$82.23M-200.8%
2020$81.60M+203.7%
2019-$78.70M-3.4%
2018-$76.14M-14.5%
2017-$66.51M-1035.7%
2016$7.11M—